Search
for
Sort by
Research 241–270 of 1000+
- 201 Analysis of mice skin distribution using MALDI-MSI after subcutaneous injections of a new potent novel inhibitor of human hair growth, FOL-005
- Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
- Alopecia in general medicine
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
- How to distinguish medicalization from over-medicalization?
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- Antiandrogen Therapy for Skin and Hair Disease
- Androgens in SARS-CoV-2 Coronavirus Infections
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- The Novel Excipient, Dodecyl-2-N, N-dimethylaminopropionate Hydrochloride (DDAIP-HCl) Improves the Flux of Minoxidil in Human Skin
- Hair Disorders
- Low-level light therapy and hair loss
- Management of Hair Loss
- Clinical Case Notes. Castleman's disease of the lacrimal gland
- Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Effects of 5-alpha reductase inhibitors
- Testosterone Treatment in Women – An Overview
- Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
- MP85-05 SEXUAL DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE: INSIGHTS FROM THE REDUCE STUDY GROUP DATABASE
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Re-Densification Effect of Pressure-Injected Peptide-Hyaluronic Acid Combination on Male Androgenic Alopecia
- Assessment of Female Sexual Dysfunction in Patients with Premenopausal Female Pattern Hair Loss
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: Is it an effective treatment?